Login to Your Account

Sinovac's hepatitis A vaccine chosen as sole supplier in Beijing

By Cornelia Zou
Staff Writer

Wednesday, July 30, 2014

HONG KONG – Leading Chinese vaccine maker Sinovac Biotech Ltd. (NASDAQ:SVA) has emerged as the sole supplier of hepatitis A vaccine in prefilled syringe dosages for the city of Beijing.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription